Treatment And Prevention of Deep Vein Thrombosis

Abstract

Deep vein thrombosis (DVT) is caused by abnormal deep vein coagulation, which is most common in the lower limbs, but sometimes it may also occur in other parts such as the subclavian vein. The main adverse consequence of DVT is pulmonary embolism (PE), which will seriously affect the quality of life of patients, and even endanger their lives. Although Paget-Schroetter syndrome (PSS) syndrome is rare, it also affects the physical and mental health of patients to a certain extent. Many factors may lead to the occurrence of this disease. Clinically, more attention should be paid to the risk factors to prevent the occurrence of the disease. At the same time, when the disease occurs, active treatment and intervention should be carried out to delay the progress of the disease. Anticoagulation is the basic treatment of DVT, which can inhibit the spread of thrombus, facilitate the autolysis of thrombus and recanalization of the lumen, and reduce the incidence and mortality of PE. At the same time, combined with other treatment programs, co-intervention.